Innovator Capital is a specialist investment bank advising emerging Biomedical and Cleantech companies from around the world. Established in 2003, Innovator focuses on the provision of expert strategic and capital markets advice, transaction arranging and M&A services for private and public companies.

Innovator's expert knowledge also enables it to provide strategic advice on political issues and corporate communications.

The firm's objective is to provide a high value-added approach to capital raising, partnering and product in and out licensing. Innovator develops tailor-made solutions to satisfy companies' individual requirements. These solutions are executed bearing in mind the limited amount of time that managements have to devote to non-operational activities, allowing them to concentrate on the execution of their business plans.

Innovator Capital has demonstrated new approaches to funding companies, in numerous world financial centres. The approaches, designed to minimise dilution to founders and existing shareholders, allow companies to determine more precisely the timing and scale of their capital raisings. Innovator benefits from the track record and multinational expertise of it's founder and the breadth and depth of knowledge across the firm.

It is at the forefront of innovation.